By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Digestive System Diseases and Conditions. According to news reporting originating in Beijing, People's Republic of China, by NewsRx journalists, research stated, "The therapeutic potential of membrane complement regulatory protein (mCRP)-neutralizing antibodies is unsatisfactory, which perhaps lies in the complex role of mCRPs in tumor occurrence and development. As a member of the mCRPs, CD46 is a transmembrane protein with a cytoplasmic domain and is implicated more in the control of the alternative complement pathway than of the classical complement pathway."
The news reporters obtained a quote from the research from the Institute of Disease Control and Prevention, "Growing evidence has revealed that both the CD46 signaling pathway and microRNAs (miRNAs) play an important role in the development and progression of hepatocellular carcinoma (HCC). In the present study, we analyzed mCRP expression in different tumor tissues by employing western blotting and qPCR. To address the potential role of miRNAs in CD46 signaling, we set out to profile miRNA expression in CD46-overexpressed and -silenced HepG2 cell lines. Furthermore, bioinformatic analysis was performed to identify downstream targets of CD46 signaling. We found that the levels of CD46 expression in HCC tissues were significantly higher compared to that in the adjacent normal tissues. After complement-related gene expression profiling and unsupervised hierarchical clustering analysis of 10 HCC tissues, a total of 37 miRNAs showed significantly different expression levels before and after CD46 expression change. By bioinformatic analysis, we identified let-7b and miR-17 as downstream targets of CD46 signaling, and that the expression levels of let-7b and miR-17 were negatively correlated with that of CD46 in HepG2 cells."
According to the news reporters, the research concluded: "The present study suggests that CD46 plays an important role in HCC carcinogenesis by regulating let-7b and miR-17."
For more information on this research see: Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma. Oncology Reports, 2014;31(2):557-64 (see also Digestive System Diseases and Conditions).
Our news correspondents report that additional information may be obtained by contacting Z. Lu, Institute of Disease Control and Prevention, Chinese Academy of Military Medical Sciences, Beijing 100071, People's Taiwan. Additional authors for this research include C. Zhang, J. Cui, Q. Song, L. Wang, J. Kang, P. Li, X. Hu, H. Song, J. Yang and Y. Sun.
Keywords for this news article include: Asia, Biotechnology, Beijing, Oncology, Bioengineering, Applied Bioinformatics, Hepatocellular Carcinoma, People's Republic of China, Digestive System Diseases and Conditions.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC